Detalhe da pesquisa
1.
Exploring the feasibility and acceptability of integrating screening for gender-based violence into HIV counselling and testing for adolescent girls and young women in Tanzania and South Africa.
BMC Public Health
; 21(1): 433, 2021 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33658000
2.
Disclosure of PrEP use by young women in South Africa and Tanzania: qualitative findings from a demonstration project.
Cult Health Sex
; 23(2): 257-272, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32129720
3.
"You talk about problems until you feel free": South African adolescent girls' and young women's narratives on the value of HIV prevention peer support clubs.
BMC Public Health
; 20(1): 1016, 2020 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32590969
4.
"It Was Not My Aim to Sleep There": The Impact of Timing and Location of Sex on Adherence to Coitally-Dependent HIV Pre-exposure Prophylaxis.
AIDS Behav
; 22(11): 3692-3704, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29909589
5.
From fear to resilience: adolescents' experiences of violence in inner-city Johannesburg, South Africa.
BMC Public Health
; 17(Suppl 3): 441, 2017 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28832282
6.
Adolescent dating violence prevention programmes: a global systematic review of evaluation studies.
Lancet Child Adolesc Health
; 5(3): 223-232, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33220790
7.
Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study.
Lancet HIV
; 8(8): e495-e501, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34126052
8.
Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial.
J Int AIDS Soc
; 23(5): e25491, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32396700
9.
Collateral benefits: how the practical application of Good Participatory Practice can strengthen HIV research in sub-Saharan Africa.
J Int AIDS Soc
; 21 Suppl 7: e25175, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334610
10.
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Infect Dis
; 18(11): 1241-1250, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30507409